HENLIUS
Summary
Henlius is a global biopharmaceutical company offering biologic medicines for patients suffering from oncology, autoimmune and ophthalmic diseases.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 543 M
Avg. Deal Size£ 543 M
Senior Management
Jason Zhu
CEO
Max Mao
CFO
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite